百億癌症新藥基金縮減至50億：打折背後的影響與挑戰 The Cancer Drug Fund Slashed to 5 Billion: Impact and Challenges

這段影片將探討「百億癌症新藥基金」從原定的百億規模縮減至50億元的影響。衛福部計劃透過這項基金來提升癌症新藥的可及性，然而預算的縮減可能會對病患的用藥權益產生深遠影響。我們將分析這次預算打折的原因、對創新藥物的影響、以及暫時性支付的挑戰，同時探討這對台灣癌症治療未來發展可能帶來的變數。

This video will discuss the impact of the "Cancer Drug Fund" being reduced from the planned 100 billion NT dollars to 50 billion. The Ministry of Health aims to improve access to new cancer drugs through this fund, but the budget cut could significantly affect patients' medication rights. We will analyze the reasons behind the budget reduction, its impact on innovative drugs, and the challenges of temporary payment. Additionally, we will explore how this budget cut might influence the future development of cancer treatment in Taiwan.